Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis
- 1Xinjiang Production and Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin, College of Life Science, Tarim University, Alar 843300, China
- 2Center for Mitochondria and Healthy Aging, School of Life Sciences, Yantai University, Yantai 264005, China
Abstract
The growing prevalence of high-fat diets and sedentary lifestyles has contributed to a marked rise in metabolic disorders and a concomitant increase in cardiovascular disease (CVD). High-fat diet-induced lipotoxicity is a key pathological driver that exacerbates myocardial ischemia/reperfusion (I/R) injury. Carnosic acid (CA), a natural bioactive compound, shows promise for cardiovascular protection through anti-inflammatory and antioxidant effects. However, the protective effects of CA against lipotoxicity-aggravated myocardial I/R injury and the molecular mechanisms involved remain incompletely understood. In this study, an isolated mouse heart was perfused with a high oleic acid (0.8 mM) solution to create a metabolic stress model of lipotoxicity. Metabolomics was applied to characterize metabolic changes in lipotoxicity-induced myocardial I/R injury. Additionally, the same model was used to investigate the potential mechanisms of action of CA (5 μM). Metabolomic analysis identified pronounced metabolic differences in isolated hearts from the normal and high-fat groups during perfusion, ischemia and reperfusion. Differential metabolites clustered primarily in energy metabolism pathways, consistent with lipotoxicity-driven metabolic derangements that worsen myocardial I/R injury. High-fat perfusion amplified the ischemic accumulation of free fatty acids and succinate in mouse myocardium, thereby aggravating I/R injury. Carnosic acid treatment markedly reversed the lipotoxicity-exacerbated cardiac I/R damage. Mechanistically, CA potentially binds to subunits adjacent to the Q site of mitochondrial complex I, decreasing reactive oxygen species (ROS) production from reverse electron transport (RET). The Sirtuin 1 (Sirt1) inhibitor selisistat (EX527) abolished CA’s protective effect, indicating that CA also modulated the Sirt1-UPRmt pathway to preserve mitochondrial homeostasis and mitigate myocardial injury.
Related
- Ellagic Acid Attenuates High-Fat, High-Sucrose Diet-Induced Cardiac Fibrosis by Suppressing AGE–RAGE Signaling, Oxidative Stress, and Inflammation
- TRPV4-linked oxidative–lysosomal stress in myocardial ischemia/reperfusion: disease-matched transcriptomics and functional analysis in OGD/R cardiomyoblasts
- Myocardial Ischemia–Reperfusion Injury: Targeted Mechanism Network and Emerging Therapeutic Strategies
- From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury
- Arctigenin Attenuates Hepatic Ischemia/Reperfusion Injury by Enhancing NRF2-GST/GPX4 Antioxidant Response
BibTeX
@article{shi2026carnosic,
title = {{Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis}},
author = {Xiaobing Shi and Man Wang and Xiaowei Zhou and Yining Diao and Yundong Fu and Gang Li and Chengjun Ma and Zhenhua Wang},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210198},
url = {https://www.mdpi.com/1422-0067/27/22/10198},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis
AU - Xiaobing Shi
AU - Man Wang
AU - Xiaowei Zhou
AU - Yining Diao
AU - Yundong Fu
AU - Gang Li
AU - Chengjun Ma
AU - Zhenhua Wang
PY - 2026
DA - 2026/11/13
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210198
UR - https://www.mdpi.com/1422-0067/27/22/10198
AB - The growing prevalence of high-fat diets and sedentary lifestyles has contributed to a marked rise in metabolic disorders and a concomitant increase in cardiovascular disease (CVD). High-fat diet-induced lipotoxicity is a key pathological driver that exacerbates myocardial ischemia/reperfusion (I/R) injury. Carnosic acid (CA), a natural bioactive compound, shows promise for cardiovascular protection through anti-inflammatory and antioxidant effects. However, the protective effects of CA against lipotoxicity-aggravated myocardial I/R injury and the molecular mechanisms involved remain incompletely understood. In this study, an isolated mouse heart was perfused with a high oleic acid (0.8 mM) solution to create a metabolic stress model of lipotoxicity. Metabolomics was applied to characterize metabolic changes in lipotoxicity-induced myocardial I/R injury. Additionally, the same model was used to investigate the potential mechanisms of action of CA (5 μM). Metabolomic analysis identified pronounced metabolic differences in isolated hearts from the normal and high-fat groups during perfusion, ischemia and reperfusion. Differential metabolites clustered primarily in energy metabolism pathways, consistent with lipotoxicity-driven metabolic derangements that worsen myocardial I/R injury. High-fat perfusion amplified the ischemic accumulation of free fatty acids and succinate in mouse myocardium, thereby aggravating I/R injury. Carnosic acid treatment markedly reversed the lipotoxicity-exacerbated cardiac I/R damage. Mechanistically, CA potentially binds to subunits adjacent to the Q site of mitochondrial complex I, decreasing reactive oxygen species (ROS) production from reverse electron transport (RET). The Sirtuin 1 (Sirt1) inhibitor selisistat (EX527) abolished CA’s protective effect, indicating that CA also modulated the Sirt1-UPRmt pathway to preserve mitochondrial homeostasis and mitigate myocardial injury.
SN - 1422-0067
ER -